The S&P 500 is nearing the 7,000 mark, hitting a record intraday high above 6,988. While the overall market is strong, some quality stocks have become oversold, presenting potential buying opportunities. Three S&P 500 components – Roper Technologies, Abbott Laboratories, and Humana – stand out as particularly oversold, with RSI readings below 30. Each of these companies is a leader in its industry and has a proven track record.

Roper Technologies reported revenue growth of 12% in 2025 and remains optimistic about AI opportunities. Abbott Laboratories saw strong growth in its continuous glucose monitoring business but faces challenges in its Nutrition segment. Humana is navigating revenue headwinds and membership uncertainties but remains focused on long-term value. Analysts recommend buying these oversold stocks, expecting them to bounce back.

Read more at Barchart: These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?